Growth Metrics

Idexx Laboratories (IDXX) Non-Current Debt (2016 - 2026)

Idexx Laboratories has reported Non-Current Debt over the past 17 years, most recently at $374.8 million for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 16.66% year-over-year to $374.8 million; the TTM value through Dec 2025 reached $374.8 million, down 16.66%, while the annual FY2025 figure was $374.8 million, 16.66% down from the prior year.
  • Non-Current Debt for Q4 2025 was $374.8 million at Idexx Laboratories, roughly flat from $374.8 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $780.1 million in Q2 2021 and troughed at $374.8 million in Q3 2025.
  • A 5-year average of $625.6 million and a median of $658.6 million in 2022 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: grew 11.67% in 2021 and later fell 28.57% in 2025.
  • Year by year, Non-Current Debt stood at $775.2 million in 2021, then decreased by 10.43% to $694.4 million in 2022, then dropped by 10.3% to $622.9 million in 2023, then decreased by 27.79% to $449.8 million in 2024, then fell by 16.66% to $374.8 million in 2025.
  • Business Quant data shows Non-Current Debt for IDXX at $374.8 million in Q4 2025, $374.8 million in Q3 2025, and $449.8 million in Q2 2025.